Pancreatic cancer
Conditions
Interventions
Experimental group (liver metastasis group):None
Control group (primary tumor group):None
Sponsors
Xuzhou Central Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Clear diagnosis: Pathologically diagnosed as pancreatic cancer with confirmed liver metastasis; 2.Surgical resection: Underwent pancreatic cancer surgery with postoperative specimens including both primary tumor tissue and liver metastasis tissue; 3.Complete clinical information: Provides comprehensive clinical data, including patient demographics, tumor staging, treatment plan, and prognosis; 4.Specimen quality: Tissue samples are well-preserved with no significant necrosis, contamination, or other conditions unsuitable for experimental analysis.
Exclusion criteria
Exclusion criteria: 1.Non-primary pancreatic cancer: For example, cancers metastasized to the pancreas from other organs (such as colorectal cancer); 2.No liver metastasis: Patients with only a primary pancreatic cancer lesion and no liver metastasis; 3.Co-existing other malignancies: Patients with other concurrent cancers that may affect the analysis of the results; 4.Severe systemic diseases: Patients with severe liver or kidney failure, infectious diseases, or other conditions that may interfere with the immune system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protein expression level; | — |
Countries
China
Contacts
Public ContactXu Wei
Xuzhou Central Hospital
Outcome results
None listed